Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Price Expected to Rise, Bank of America Analyst Says
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its price target increased by Bank of America from $302.00 to $325.00 in a report published on Friday,Benzinga reports. The firm currently has a buy rating on the biopharmaceutical company’s stock. ALNY has been the topic of several other research reports. William Blair restated an “outperform” rating on […]
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its price target increased by Bank of America from $302.00 to $325.00 in a report published on Friday,Benzinga reports. The firm currently has a buy rating on the biopharmaceutical company’s stock. ALNY has been the topic of several other research reports. William Blair restated an “outperform” rating on […]
